EXION Fractional RF Skin Tightening
PFRANKMD is proud to offer EXION Fractional RF treatments for needleless radiofrequency (RF) skin tightening and rejuvenation. When radiofrequency energy is absorbed into sub dermal skin tissue layers it prompts increased collagen production, previous advances to achieve deeper delivery have used microneedling applicators for the energy to pass through, EXION Fractional RF treatments deliver radiofrequency energy to an unprecedented depth without a single needle.
What Is EXION Fractional RF?
Developed by the experts at BTL Aesthetics, makers of EMSCULPT and EMFACE, the EXION fractional RF device is just one of four face and body skin rejuvenation options on a single platform that offers skin tightening to 23 different parts of the body. EXION features integrated artificial intelligence (AI) with customizable settings that are adaptable to each patient’s treatment needs and ensure safety.
How Does EXION Fractional RF Work?
EXION Fractional RF treatments deliver the benefits of radiofrequency energy into the deep layers of skin tissue with monopolar radiofrequency technology that uses a single electrode placed at the skin surface. The radiofrequency energy is safely converted to thermal energy as it is absorbed, this process prompts the body to activate a healing reaction of increased collagen production. The result is the emergence of skin that appears more youthful, with a smoother texture and firmer tone.
Ideal Candidates
EXION candidates are seeking a non-surgical treatment to regain youthful skin texture and address isolated areas of mild to moderate skin laxity, the artificial intelligence (AI) controlled settings and safety feature offers skin rejuvenation to a wider range of patients.
A consultation at PFRANKMD ensures the patients compatibility, and that their aesthetic concerns and goals for treatment align with the results potential of EXION Fractional RF. Patients who are candidates for EXION may need more than one treatment session to achieve their desired result, two to four treatments has been shown to produce maximum results.
The EXION Fractional RF Procedure
Fractional radiofrequency treatments with EXION are performed in one of our treatment suites and are completed in under an hour in most cases. The needless delivery of radiofrequency energy makes for a painless treatment, patients may feel tingling or a warm sensation.
Results and Recovery
The recovery from EMFEMME 360 does not require downtime. Patients can resume their regular activities upon leaving their appointment. Patients may experience mild redness or residual warmth in the treatment area that fades quickly. Most patients report noticeable results after one treatment and reach their goals for improvement after three sessions.
Schedule a Consultation
Ready to learn more about how the Exion Fractional RF can help you? Contact PFRANKMD to schedule a consultation at our 5th Avenue or West Village location in NYC.
FAQs
Can EXION Fractional RF Treatments be Used in Combination with Other Treatments?
Yes, EXION Fractional RF treatments can be combined with other face and body rejuvenation treatments. Dr. Frank or a PFRANKMD team member can assist with more information on recommended companion treatments.
Are There any Age Restrictions for EXION Fractional RF Treatments?
There are no specific age restrictions, suitability for the treatment depends on individual patient factors as determined by the doctor’s assessment of the intended treatment area and the patient’s health history and goals for treatment.
Are EXION Fractional RF Treatments Safe for Sensitive Skin?
Yes, the treatment is safe sensitive skin and the EXION platform features adjustable settings and artificial intelligence powered (AI) safety monitoring during the treatment. It is essential though to share any concerns or details of past episodes of sensitivity or allergic reactions.
Are EXION Fractional RF Treatments Recommended for Patients Who are Pregnant or Breastfeeding?
No, any type of fractional radiofrequency treatments is not recommended for patients who are pregnant or breastfeeding. Clinical trials on these treatments have not included these patients, so safety and efficacy data is limited in these situations.